The University of California Irvine (UCI) Sue & Bill Gross Stem Cell Research Center (SCRC; www.stemcell.uci.edu) and School of Medicine (SOM, https://www.som.uci.edu) invite applications from outstanding candidates for a tenured faculty position (open rank) as Associate Director for Cell and Gene Therapy. Goals of this position are to enhance: investigator-initiated clinical trials for FDA regulated cell & biotechnologies; access of UCI Health clients to public-private partnership initiated FDA regulated clinical trials for cell technologies aligned with institutional strengths; advanced biotherapeutics and clinical services operations in alignment with the UCI Health mission; and workforce development to support translational advances in cell and gene therapy/regenerative medicine. This position will report to the SCRC Director, with parallel reporting to the Gene Therapy faculty oversight committee, and oversee the Medical Director and operations of the GMP facility.
This academic appointment is open to MD or MD/PhD scientists, and will be at the Associate or Full Professor level in an appropriate SOM department; start-up package commensurate with appointment level. DO and MBSS candidates will also be considered. Candidates are expected to bring a robust extramurally funded research program with a clinical translation focus in cell and gene therapy/regenerative medicine. Successful candidates will have significant expertise in clinical pathway development, IND submission and regulatory processes, and GMP cell manufacturing, as well as development of academic-industry partnerships. The candidate’s areas of research should complement translational foci in the SOM and College of Health Sciences (COHS), including but not limited to autologous and allogeneic cellular therapies for cancer and neurological disease. In keeping with the commitment of UCI to inclusive excellence, applicants must provide a statement addressing past and/or potential contributions to diversity, equity and inclusion.
UCI SOM/COHS programs include strong resources across multiple translational themes, including the SCRC (www.stemcell.uci.edu) and California Institute of Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC; https://clinic.stemcell.uci.edu); Institute for Clinical and Translational Science (http://www.icts.uci.edu); Chao Family Comprehensive Cancer Center (http://www.cancer.uci.edu); Cancer Research Institute (http://cri.bio.uci.edu); and Institute for Immunology (http://www.immunology.uci.edu).
Interested individuals should apply online through UCI RECRUIT at: https://recruit.ap.uci.edu/JPF08021
Application requirements: 1) Cover letter; 2) Curriculum vitae; 3) Summary of research interests (up to 3 pages); 4) Summary of teaching philosophy (1 page); 5) Names and contact information for 3-5 individuals to provide a letter of reference upon request; 6) Statement of Contributions to Diversity; 7) PDFs of 3-5 recent publications.
Applications should be submitted by May 31, 2023 for full consideration.
Inquiries should be directed to: Rachel Charney, MD, [email protected]
, at Grant Cooper.
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy. A recipient of an NSF ADVANCE award for gender equity, UCI is responsive to the needs of dual career couples, supports work-life balance through an array of family-friendly policies, and is dedicated to broadening participation in higher education.